StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
49
This year
1
Publishing Date
2024 - 01 - 24
1
2023 - 11 - 10
1
2023 - 10 - 04
1
2023 - 10 - 03
1
2023 - 09 - 07
1
2023 - 08 - 16
1
2023 - 08 - 08
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 14
1
2023 - 06 - 01
1
2023 - 05 - 29
1
2023 - 05 - 03
1
2023 - 04 - 14
1
2023 - 03 - 28
1
2023 - 02 - 20
1
2023 - 02 - 08
1
2023 - 01 - 30
2
2023 - 01 - 26
2
2023 - 01 - 16
1
2023 - 01 - 09
1
2023 - 01 - 02
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 12 - 26
1
2022 - 12 - 01
1
2022 - 11 - 18
1
2022 - 09 - 28
1
2022 - 08 - 26
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 29
1
2022 - 07 - 20
1
2022 - 07 - 05
1
2022 - 06 - 27
1
2022 - 06 - 24
2
2022 - 06 - 09
1
2022 - 06 - 03
2
2022 - 05 - 26
1
2022 - 04 - 26
3
2022 - 03 - 23
1
2022 - 02 - 08
1
2021 - 05 - 04
1
Sector
Communications
1
Consumer non-durables
1
Health services
1
Health technology
49
Manufacturing
8
N/a
3
Professional, scientific, and technical services
2
Tags
Acquisition
9
Active
10
Antiviral
10
Application
24
Approval
31
Authorization
14
Breast
12
Cancer
66
Candidate
16
Children
18
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
15
Collaboration
21
Comirnaty®
10
Conference
18
Covid
58
Covid-19
41
Disease
28
Drug
54
Earnings
20
Ema
10
Emergency use authorization
10
Europe
13
Events
12
Expected
10
Fda
74
Fda-approvals
14
Financial
19
Global
56
Growth
29
Hiv
15
Hormone
10
License
19
Market
100
Merge
15
N/a
432
Order
15
People
24
Pharm-country
33
Pharmaceutical
17
Phase 2
12
Phase 3
21
Positive
45
Potential
11
Product-news
10
Regulatory
12
Report
49
Research
51
Respiratory
10
Results
62
Risk
16
Study
20
Therapeutics
40
Therapy
29
Topline
14
Treatment
73
Trial
47
Ulcerative colitis
12
Update
14
Vaccine
106
Entities
3m company
194
Abb ltd
199
Abbott laboratories
306
Abbvie inc.
97
Accenture plc
70
Aecom
94
Agilent technologies, inc.
90
Alphabet inc.
87
Apple inc.
120
Arrival
149
Astrazeneca plc
95
Becton, dickinson and company
182
Bio-rad laboratories, inc.
122
Boston scientific corporation
86
Cisco systems, inc.
118
Clariant ag
69
Cnh industrial n.v.
81
Cummins inc.
71
Danaher corporation
184
Deere & company
73
Denso corp
97
Dow inc.
83
Dupont de nemours, inc.
90
Eastman chemical company
70
Eli lilly and company
141
Ericsson
250
Exxon mobil corporation
93
Ferrari n.v.
79
Ford motor company
71
General dynamics corporation
68
General electric company
180
Glaxosmithkline plc
140
Honeywell international inc.
316
Huntsman corporation
74
Illumina, inc.
69
Infineon technologies ag
97
Intel corporation
166
International business machines corporation
96
Johnson & johnson
345
Koninklijke philips n.v.
174
Linde plc
78
Lockheed martin corporation
155
Medtronic plc
165
Microsoft corporation
268
Nec corp
116
Nokia corp
71
Northrop grumman corporation
127
Novartis ag
195
Nvidia corporation
75
Oracle corporation
204
Orange
251
Panasonic corp
148
Qiagen n.v.
94
Raytheon technologies corporation
94
Sanofi
312
Sap se
162
Stryker corporation
82
Teva pharmaceutical industries ltd
95
Thermo fisher scientific inc
307
Zte corp
85
Symbols
ABBV
2
ABT
6
ADXS
1
AERI
1
ALC
1
ALKS
1
ALNY
1
ALPMF
4
ALPMY
4
ANIK
2
AUTL
1
AZN
15
AZNCF
15
BAX
1
BDX
1
BEAM
1
BHVN
2
BMY
11
BNTX
4
CDTX
1
CLVS
1
CLVSQ
1
CMXHF
1
CSLLY
1
CVM
1
DHR
2
EBS
1
EMMA
1
ENDP
1
EXEL
1
FNCTF
1
GBT
1
GILD
4
GLAXF
7
GSK
7
HOLX
1
ICLR
1
INCY
1
INO
1
IONS
3
IRWD
1
JNJ
14
KURA
1
LLY
15
LXRX
1
LZAGF
1
LZAGY
1
NBIX
2
NVO
4
NVS
18
NVSEF
18
PFE
49
PTCT
2
SNY
18
SNYNF
18
TAK
10
TEVJF
10
UCBJF
2
UCBJY
2
VTRS
2
Exchanges
Amex
1
Nasdaq
42
Nyse
49
Crawled Date
2024 - 01 - 24
1
2023 - 11 - 10
1
2023 - 10 - 04
1
2023 - 10 - 03
1
2023 - 09 - 07
1
2023 - 08 - 16
1
2023 - 08 - 08
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 14
1
2023 - 06 - 01
1
2023 - 05 - 29
1
2023 - 05 - 03
1
2023 - 04 - 14
1
2023 - 03 - 28
1
2023 - 02 - 20
1
2023 - 02 - 08
1
2023 - 01 - 30
2
2023 - 01 - 27
1
2023 - 01 - 26
1
2023 - 01 - 16
1
2023 - 01 - 09
1
2023 - 01 - 02
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 12 - 26
1
2022 - 12 - 01
1
2022 - 11 - 18
1
2022 - 09 - 28
1
2022 - 08 - 26
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 29
1
2022 - 07 - 20
1
2022 - 07 - 05
1
2022 - 06 - 27
1
2022 - 06 - 24
2
2022 - 06 - 09
1
2022 - 06 - 03
2
2022 - 05 - 26
1
2022 - 04 - 26
3
2022 - 03 - 23
1
2022 - 02 - 08
1
2021 - 05 - 04
1
Crawled Time
00:00
1
01:00
4
02:00
1
05:00
1
06:00
1
07:00
1
09:00
1
11:00
1
12:00
7
13:20
2
14:00
2
15:00
5
15:20
3
16:00
2
17:00
4
18:00
3
19:00
2
20:00
1
21:00
2
22:00
3
23:00
2
Source
www.biospace.com
4
www.globenewswire.com
3
www.prnewswire.com
42
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Report
entities :
Pfizer, inc.
save search
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-8.55%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-12.41%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-33.33%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-16.0%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
-18.12%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published:
2023-11-10
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
7.35%
|
O:
0.1%
H:
0.0%
C:
-2.14%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-19.35%
|
O:
-3.48%
H:
3.87%
C:
3.61%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-12.4%
|
O:
0.24%
H:
0.22%
C:
-0.91%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-1.41%
|
O:
-1.24%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.94%
|
O:
0.4%
H:
0.18%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
20.55%
|
O:
0.44%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
6.96%
|
O:
-1.33%
H:
0.22%
C:
-0.11%
report
research
market
Global Vulvovaginal Candidiasis Treatment Market Research Report 2023-2028 - Demand for Cost-effective Vulvovaginal Candidiasis Treatment Soars with Growing Geriatric Population
Published:
2023-10-04
(Crawled : 23:00)
- prnewswire.com
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-29.68%
|
O:
0.59%
H:
0.29%
C:
0.22%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-21.95%
|
O:
0.42%
H:
0.99%
C:
0.06%
SCYX
|
$1.44
2.49%
2.43%
130K
|
Health Technology
|
-35.14%
|
O:
0.45%
H:
4.04%
C:
0.45%
CDTX
|
$0.6855
-5.06%
-5.32%
350K
|
Health Technology
|
-26.88%
|
O:
0.39%
H:
10.33%
C:
3.9%
report
treatment
candidiasis
research
global
growing
market
Global Rare Hemophilia Factors Market Analysis Report 2023-2030 - Tailored Factor Concentrates Gain FDA Approval, Fueling Rare Hemophilia Factors Market Growth
Published:
2023-10-03
(Crawled : 01:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-23.39%
|
O:
-0.29%
H:
0.8%
C:
0.18%
fda
rare
report
global
growth
market
Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Published:
2023-09-07
(Crawled : 05:00)
- globenewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-24.35%
|
O:
0.29%
H:
0.49%
C:
-0.55%
candidate
disease
report
vaccine
positive
valneva
results
phase 2
Global Hemophilia Research Analysis Report 2023: A $21.07 Billion Market by 2030 - Approval of Gene Therapies and Monoclonal Antibodies Fueling Growth
Published:
2023-08-16
(Crawled : 01:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-12.84%
|
O:
-0.26%
H:
0.26%
C:
-0.46%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-26.53%
|
O:
-0.71%
H:
1.45%
C:
0.97%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
32.58%
|
O:
-0.3%
H:
1.35%
C:
0.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.0%
|
O:
-1.33%
H:
0.0%
C:
0.0%
report
approval
research
global
growth
market
North America Kidney Transplant Research Report 2023
Published:
2023-08-08
(Crawled : 22:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
12.8%
|
O:
1.11%
H:
0.53%
C:
0.53%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-36.71%
|
O:
3.93%
H:
0.0%
C:
-3.08%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-27.05%
|
O:
-0.11%
H:
1.29%
C:
0.67%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.43%
|
O:
-0.07%
H:
0.73%
C:
0.36%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
-5.3%
|
O:
-1.98%
H:
1.7%
C:
0.81%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.33%
|
O:
0.81%
H:
0.0%
C:
0.0%
america
report
kidney
research
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.04%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-29.52%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.18%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.61%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.59%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
60.42%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.48%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-4.43%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Global Doxorubicin Strategic Analysis Report 2023: A $1.7 Billion Market by 2030 from $1.1 Billion in 2022 - US Dominates the Market, Asia-Pacific to Witness Fastest Growth
Published:
2023-06-14
(Crawled : 19:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.94%
|
O:
0.13%
H:
1.07%
C:
0.86%
report
global
doxorubicin
growth
market
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-7.79%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.61%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.68%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-31.61%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-22.33%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.83%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.35%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.84%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-5.89%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Antivenoms Global Market Report 2023: Sector to Reach $2.3 Billion by 2030 at a 7.4% CAGR
Published:
2023-05-29
(Crawled : 22:00)
- prnewswire.com
CSLLY
|
$86.918
3.3%
60K
|
n/a
|
-12.83%
|
O:
0.77%
H:
0.52%
C:
-0.4%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-30.85%
|
O:
-0.64%
H:
0.0%
C:
-0.94%
report
reach
global
market
Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18.1 Billion by 2030 at a 42.5% CAGR
Published:
2023-05-03
(Crawled : 18:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-32.38%
|
O:
-0.73%
H:
0.68%
C:
0.16%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
68.44%
|
O:
0.06%
H:
0.29%
C:
-0.7%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.58%
|
O:
-0.29%
H:
1.19%
C:
0.56%
PTCT
|
News
S
|
$25.32
2.55%
2.49%
3.9M
|
Health Technology
|
-54.3%
|
O:
-0.38%
H:
1.38%
C:
1.2%
LXRX
|
$1.655
1.53%
1.51%
3M
|
Health Technology
|
-39.78%
|
O:
2.19%
H:
13.21%
C:
10.0%
report
reach
global
duchenne
market
Stomach Cancer Treatment Market Report 2023: Growing Demand for Painless Low-Cost Treatment and Favorable Reimbursement Scenarios Bolsters Sector
Published:
2023-04-14
(Crawled : 02:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-37.3%
|
O:
0.08%
H:
0.49%
C:
-0.76%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
93.61%
|
O:
-0.24%
H:
0.55%
C:
0.13%
report
favorable
cancer
treatment
growing
market
Global Peptide Antibiotics Market Report 2022: Sector to Reach $5.74 Billion in 2026 at a CAGR of 8%
Published:
2023-03-28
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
18.75%
|
O:
3.17%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-35.36%
|
O:
-0.05%
H:
0.25%
C:
-0.52%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
4.52%
|
O:
-0.38%
H:
1.25%
C:
1.12%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
13.44%
|
O:
0.26%
H:
0.17%
C:
-0.09%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
117.07%
|
O:
0.36%
H:
0.9%
C:
0.55%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.7%
|
O:
2.06%
H:
0.0%
C:
0.0%
report
antibiotics
global
market
Antiglaucoma Drugs Global Market Report 2023
Published:
2023-02-20
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AERI
|
$15.25
0.0%
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
global
report
market
Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published:
2023-02-08
(Crawled : 16:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-40.35%
|
O:
-0.09%
H:
1.26%
C:
0.99%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.48%
|
O:
-0.06%
H:
0.77%
C:
0.19%
EBS
|
$2.04
9.68%
0.49%
930K
|
Health Technology
|
-85.53%
|
O:
-0.78%
H:
0.79%
C:
-5.29%
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-93.63%
|
O:
-0.07%
H:
4.9%
C:
2.27%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.02%
|
O:
3.05%
H:
0.0%
C:
0.0%
NVAX
|
$3.99
2.57%
2.51%
2.9M
|
Health Technology
|
-63.54%
|
O:
0.0%
H:
1.74%
C:
-4.13%
INO
4 d
|
$9.68
-5.1%
-5.37%
350K
|
Health Technology
|
420.43%
|
O:
-1.61%
H:
2.73%
C:
-8.47%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-38.92%
|
O:
-1.35%
H:
1.53%
C:
0.68%
research
global
report
vaccine
market
Joint Pain Injections Global Market Report 2022: Hyaluronic Acid Leads the Way Due to Excellent Lubrication and Shock Absorbing Properties
Published:
2023-01-30
(Crawled : 17:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-40.63%
|
O:
0.0%
H:
0.79%
C:
-0.55%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.56%
|
O:
0.95%
H:
0.0%
C:
0.0%
ANIK
|
$25.84
1.61%
1.59%
49K
|
Health Technology
|
-15.72%
|
O:
-0.85%
H:
1.17%
C:
-1.09%
global
report
market
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published:
2023-01-30
(Crawled : 17:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.91%
|
O:
1.09%
H:
2.18%
C:
-1.43%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.4%
|
O:
-0.19%
H:
0.13%
C:
-0.69%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-40.63%
|
O:
0.0%
H:
0.79%
C:
-0.55%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-12.08%
|
O:
-0.18%
H:
0.36%
C:
-3.53%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.43%
|
O:
-0.13%
H:
0.78%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.61%
|
O:
1.3%
H:
0.06%
C:
-0.81%
global
report
gastrointestinal
therapeutics
market
Global Infertility Drugs Market Report 2022: Sector to Reach $4.8 Billion by 2028 at a 6.2% CAGR
Published:
2023-01-26
(Crawled : 00:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-41.24%
|
O:
-0.07%
H:
0.27%
C:
-0.97%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
5.03%
|
O:
-0.56%
H:
0.73%
C:
0.17%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.41%
|
O:
-0.38%
H:
0.55%
C:
-0.63%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.75%
|
O:
-1.25%
H:
0.0%
C:
0.0%
global
report
market
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.